KAINAIR Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Kainair, and when can generic versions of Kainair launch?
Kainair is a drug marketed by Pharmafair and is included in one NDA.
The generic ingredient in KAINAIR is proparacaine hydrochloride. There is one drug master file entry for this compound. Six suppliers are listed for this compound. Additional details are available on the proparacaine hydrochloride profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Kainair
A generic version of KAINAIR was approved as proparacaine hydrochloride by BAUSCH AND LOMB on September 29th, 1995.
Summary for KAINAIR
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 47 |
Patent Applications: | 4,139 |
Formulation / Manufacturing: | see details |
DailyMed Link: | KAINAIR at DailyMed |
US Patents and Regulatory Information for KAINAIR
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Pharmafair | KAINAIR | proparacaine hydrochloride | SOLUTION/DROPS;OPHTHALMIC | 088087-001 | Jun 7, 1983 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |